NAUT Stock Price, Chart, Stats & News
Nautilus Biotechnolgy, Inc. (NAUT) does not currently pay a dividend.
NAUT chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -30.87% |
ROE | -33.64% |
D/E | 0.19x |
Interest coverage ratio | – |
NAUT valuation
P/E | – |
P/S | – |
P/B | 2.80x |
P/CF | -8.67x |
P/FCF | -8.47x |
P/OCF | -8.67x |
PEG | -1.24x |
EV multiple | -8.05x |
About
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples.
Similar securities
Based on sector and market capitalization
